Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells

Oncogene

Volumn 18, Issue 36, 1999, Pages 5044-5053

  Glaser, Tamara ^a   Wagenknecht, Bettina ^a   Groscurth, Peter ^b   Krammer, Peter H ^c   Weller, Michael ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Caspases; CD95; Chemotherapy; Glioma

Indexed keywords

CAMPTOTHECIN; CARMUSTINE; CASPASE; CASPASE INHIBITOR; CISPLATIN; CYCLOHEXIMIDE; CYTARABINE; CYTOTOXIC AGENT; DACTINOMYCIN; DNA FRAGMENT; ETOPOSIDE; FAS ANTIGEN; TENIPOSIDE; UNCLASSIFIED DRUG; VINCRISTINE; ZVAD FMK;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL DEATH; CONTROLLED STUDY; DRUG CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; ENZYME ACTIVATION; GLIOMA; HUMANS; MICROSCOPY, ELECTRON; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033539041     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202882     Document Type: Article

References (30)

1. Antoku K, Liu Z and Johnson DE. (1997). Leukemia, 11, 1665-1672.
2. Benjamin CW, Hiebsch RR and Jones DA. (1998). Mol. Pharmocol., 53, 446-450.
3. Datta R, Banach D, Kojima H, Talanian RV, Alnenmri ES, Wong WW and Kufe DW. (1996). Blood. 88, 1936-1943.
4. Droin N, Dubrez L, Renvoizé C, Bréard J, Dimanche-Boitrel MT and Solary E. (1998). Oncogene, 16, 2885-2894.
5. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ and Kaufmann SH. (1997). Blood, 90, 935-943.
6. Faleiro L, Kobayashi R, Fearnhead H and Lazebnik Y. (1997). EMBO J., 16, 2271-2281.
7. Ferrari D, Stepczynska A, Los M, Wesselborg S, Schulze-Osthoff K. (1998). J. Exp. Med., 188, 979-984.
8. Friesen C, Herr I, Krammer PH and Debatin KM. (1996). Nature Med., 2, 574-577.
9. Fulda S, Sieverts H, Friesen C, Herr I and Debatin KM. (1997). Cancer Res., 57, 3823-3829.
10. Fulda S, Los M, Friesen C and Debatin KM. (1998a). Int. J. Cancer, 76, 105-114.
11. Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME and Debatin KM. (1998b). Cell Death Differ., 5, 884-893.
12. Kataoka T, Schröter M, Hahne M, Schneider P. Irmler M, Thome M, Froelich CJ, Tschopp J. (1998). J. Immunol., 161, 3936-3942.
13. Kondo S, Barna BP, Morimura T, Takeuchi J, Yuan J, Akbasak A and Barnett GH. (1996). Cancer Res., 55, 6166-6171.
14. Kondo S, Tanaka Y, Kondo Y, Ishizaka Y, Hitomi M. Haqqi T, Liu J, Barnett GH, Alnemri ES and Barna BP. (1998). Cancer Res., 58, 962-967.
15. Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K and Debatin KM. (1997). Blood, 90, 3118-3129.
16. Martins LM, Mesner PW, Kottke TJ, Basi GS, Sinha S, Tung JS, Svingen PA, Madden BJ, Takahashi A. McCormick D, Earnshaw WC and Kaufmann SH. (1997). Blood, 90, 4283-4296.
17. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hoffmann WJ, Stremmel W, Krammer PH and Galle R (1997). J. Clin. Invest., 99, 403-413.
18. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH and Peter ME. (1998). EMBO J., 17, 1675-1687.
19. Strasser A, Harris AW, Huang DC, Krammer PH and Cory S. (1995). EMBO J., 14, 6136-6147.
20. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckman JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Sofrer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P anal Wallach D. (1998). Immunity, 9, 267-276.
21. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R and Greil R. (1997). Cancer Res., 57, 3331-3334.
22. Wagenknecht B, Schulz JB, Gulbins E and Weller M. (1998). Cell Death Differ., 5, 894-900.
23. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y and Fontana A. (1994). J. Clin. Invest., 94, 954-964.
24. Weller M, Weinstock C, Will C, Wagenknecht B, Dichgans J, Lang F and Gulbins E. (1997). Cell. Physiol. Biochem., 7, 282-288.
25. Weller M, Kleihues P, Dichgans J and Ohgaki H. (1998a). Brain Pathol., 8, 285-293.
26. Weller M, Rieger J, Grimmel C, Van Meir EG, De Tribolet N, Krajewski S, Reed JC, Von Deimling A and Dichgans J. (1998b). Int. J. Cancer. 79, 640-644.
27. Winter S, Roth W, Dichgans J and Weller M. (1998). Eur. J. Pharmacol., 341, 323-328.
28. Yu JS, Sena-Esteves M, Paulus W, Breakefield XO and Reeves SA. (1996). Cancer Res., 56, 5423-5427.
29. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM and Salvesen GS. (1997). J. Biol. Chem., 272, 7797-7800.
30. Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Krammer PH and Weller M. (1997). J. Immunol., 159, 2108-2115.